查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1760734

2025年腫瘤分析全球市場報告

Tumor Profiling Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年腫瘤分析市場規模將快速成長。 2029年，該市場規模將成長至164.8億美元，複合年成長率為10.1%。預測期內的預期成長可歸因於多種因素，例如液態切片技術的普及、癌症研發投入的增加、人口老化、標靶治療的應用範圍擴大以及癌症研究合作的增加。預計影響這一時期的關鍵趨勢包括向伴隨診斷的轉變、多基因檢測的興起、次世代定序的創新、人工智慧 (AI) 在癌症診斷中的應用以及腫瘤分析技術的進步。

個人化醫療需求的不斷成長預計將在未來幾年推動腫瘤分析市場的成長。個人化醫療根據每位患者的體徵量身訂做醫療保健方案，與傳統治療相比，它能提供更精準的治療、更好的療效和更少的副作用。腫瘤分析在個人化醫療中發揮關鍵作用，它能識別患者腫瘤中的特定基因突變和生物標記物，從而實現標靶治療，同時將副作用降至最低。例如，2024 年 2 月，美國個人化醫療推廣組織個人化醫療聯盟報告稱，個人化醫療將佔 2023 年新藥認證的三分之一以上，這一趨勢將連續第四年持續。因此，個人化醫療需求的不斷成長正在推動腫瘤分析市場的擴張。

為了提高癌症治療的準確性和效率，腫瘤分析市場的主要企業越來越注重開發先進的解決方案，包括由人工智慧 (AI) 驅動的診斷工具。 AI 包括先進的計算技術，可分析複雜的基因組、蛋白質組和臨床數據，從而促進更快的診斷、個人化治療計劃和更好地監測疾病進展。例如，2025 年 1 月，專門從事人工智慧驅動的癌症診斷和治療軟體的英國公司 Panakeia Technologies LTD 推出了 PANProfiler Colon。這款人工智慧軟體專門使用結腸癌組織樣本的 H 和 E 染色影像來分析關鍵的分子生物標記物，例如微衛星不穩定性 (MSI) 和錯配修復缺陷 (dMMR)。該工具可以快速準確地對腫瘤進行分子分析，這對於診斷結腸癌、識別林奇症候群和確定個人化治療至關重要。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤學概況 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球腫瘤分析市場：成長率分析
  • 全球腫瘤分析市場表現：規模與成長，2019-2024
  • 全球腫瘤分析市場預測：規模與成長，2024-2029 年，2034 年
  • 全球腫瘤分析總目標市場（TAM）

第6章市場區隔

  • 全球腫瘤分析市場（按技術、性能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 基因組學
  • 蛋白質體學
  • 表觀遺傳學
  • 代謝體學
  • 全球腫瘤分析市場（按技術、性能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 定序技術
  • 定量聚合酵素鏈鎖反應（qPCR）
  • 免疫組織化學
  • 原位雜合技術（ISH）
  • 微陣列
  • 全球腫瘤分析市場的應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 個人化癌症治療
  • 腫瘤診斷
  • 調查
  • 全球腫瘤分析市場、基因體學細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列
  • 桑格定序
  • 全球腫瘤分析市場蛋白質體學細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 質譜法（MS）
  • 蛋白質微陣列
  • 免疫組織化學（IHC）
  • 西方印漬術
  • 全球腫瘤分析市場表觀遺傳學細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • DNA甲基化分析
  • 染色質免疫沉澱定序（ChIP-seq）
  • 組蛋白修飾分析
  • 非編碼RNA分析
  • 全球腫瘤分析市場代謝體學組學細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 核磁共振（NMR）光譜
  • 氣相層析法質譜法（GC-MS）
  • 液相層析法質譜法（LC-MS）
  • 毛細管電泳質譜法（CE-MS）

第7章 區域和國家分析

  • 全球腫瘤分析市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤分析市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 腫瘤分析市場：競爭格局
  • 腫瘤分析市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Guardant Health Inc.
  • GenScript Biotech Corporation
  • NeoGenomics Inc.
  • Caris Life Sciences Inc.
  • Tempus Inc.
  • Foundation Medicine Inc.
  • NanoString Technologies Inc.
  • Personalis Inc.
  • Boreal Genomics Inc.
  • Strand Life Sciences Pvt. Ltd.
  • HTG Molecular Diagnostics Inc.
  • Lucence Health Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年腫瘤分析市場：提供新機會的國家
  • 2029年腫瘤分析市場：細分領域蘊含新機會
  • 2029年腫瘤分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35611

Tumor profiling is a collection of methods used to examine and characterize the genetic and molecular characteristics of a tumor. This process helps identify specific mutations, gene expression patterns, and other molecular traits of cancer cells, providing valuable insights into the biology of the tumor. It also aids in treatment decision-making and supports the development of personalized therapies.

The primary techniques used in tumor profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics involves studying the genetic material (DNA) of cancer cells to identify genetic alterations that drive tumor formation and progression. It uses technologies such as sequencing, quantitative polymerase chain reaction (qPCR), immunohistochemistry, in situ hybridization (ISH), and microarrays. These techniques are commonly applied in personalized cancer treatment, oncological diagnostics, and research.

The tumor profiling market research report is one of a series of new reports from The Business Research Company that provides tumor profiling market statistics, including tumor profiling industry global market size, regional shares, competitors with a tumor profiling market share, detailed tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor profiling industry. This tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor profiling market size has grown rapidly in recent years. It will grow from $10.16 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer cases, growing demand for personalized medicine, increased healthcare spending, wider adoption of companion diagnostics, and heightened awareness of the importance of early cancer detection.

The tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated during the forecast period can be attributed to factors such as the increasing adoption of liquid biopsy techniques, rising investments in cancer research and development, an aging population, the expanding use of targeted therapies, and a growing number of cancer research collaborations. Key trends expected to shape this period include a shift toward companion diagnostics, an increase in multi-gene testing, technological innovations in next-generation sequencing, the integration of artificial intelligence (AI) in cancer diagnostics, and advancements in tumor profiling technologies.

The growing demand for personalized medicine is expected to fuel the growth of the tumor profiling market in the coming years. Personalized medicine tailors healthcare treatments to the unique characteristics of each patient, offering more precise therapies with better outcomes and fewer side effects compared to traditional treatments. Tumor profiling plays a key role in personalized medicine by identifying specific genetic mutations and biomarkers in a patient's tumor, enabling targeted therapies that minimize side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based organization focused on advancing personalized medicine, reported that personalized medicines accounted for over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. As a result, the rising demand for personalized medicine is driving the expansion of the tumor profiling market.

Leading companies in the tumor profiling market are increasingly focusing on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to improve the accuracy and efficiency of cancer treatment. AI involves the use of advanced computational techniques to analyze complex genomic, proteomic, and clinical data, facilitating faster diagnoses, personalized treatment plans, and better disease progression monitoring. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), using H and E-stained images of colon cancer tissue samples. The tool allows for rapid and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying Lynch syndrome, and guiding personalized treatment decisions.

In February 2024, Myriad Genetics Inc., a U.S.-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG) for an undisclosed amount. This acquisition bolsters Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and its CLIA-certified laboratory in St. George, Utah, all aimed at advancing patient care. Intermountain Precision Genomics is a US-based division specializing in molecular diagnostics, genomic testing, and tumor profiling.

Major players in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor profiling market includes revenues earned by entities by providing services such as biomarker testing, methylation profiling, and clinical trial matching. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor profiling market also includes sales of liquid biopsy kits, immunohistochemistry (IHC) kits, and methylation profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
  • 2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
  • 3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
  • Subsegments:
  • 1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
  • 2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
  • 3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
  • 4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Profiling Market Characteristics

3. Tumor Profiling Market Trends And Strategies

4. Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tumor Profiling Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Profiling Market Growth Rate Analysis
  • 5.4. Global Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Profiling Total Addressable Market (TAM)

6. Tumor Profiling Market Segmentation

  • 6.1. Global Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics
  • 6.2. Global Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Techniques
  • Quantitative Polymerase Chain Reaction (qPCR)
  • Immunohistochemistry
  • In Situ Hybridization (ISH)
  • Microarray
  • 6.3. Global Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Personalized Cancer Medicine
  • Oncological Diagnostics
  • Research
  • 6.4. Global Tumor Profiling Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • Sanger sequencing
  • 6.5. Global Tumor Profiling Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry (MS)
  • Protein Microarrays
  • Immunohistochemistry (IHC)
  • Western Blotting
  • 6.6. Global Tumor Profiling Market, Sub-Segmentation Of Epigenetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Methylation Analysis
  • Chromatin Immunoprecipitation Sequencing (ChIP-seq)
  • Histone Modification Profiling
  • Non-Coding RNA Analysis
  • 6.7. Global Tumor Profiling Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nuclear Magnetic Resonance (NMR) Spectroscopy
  • Gas Chromatography-Mass Spectrometry (GC-MS)
  • Liquid Chromatography-Mass Spectrometry (LC-MS)
  • Capillary Electrophoresis-Mass Spectrometry (CE-MS)

7. Tumor Profiling Market Regional And Country Analysis

  • 7.1. Global Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Profiling Market

  • 8.1. Asia-Pacific Tumor Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Profiling Market

  • 9.1. China Tumor Profiling Market Overview
  • 9.2. China Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Profiling Market

  • 10.1. India Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Profiling Market

  • 11.1. Japan Tumor Profiling Market Overview
  • 11.2. Japan Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Profiling Market

  • 12.1. Australia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Profiling Market

  • 13.1. Indonesia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Profiling Market

  • 14.1. South Korea Tumor Profiling Market Overview
  • 14.2. South Korea Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Profiling Market

  • 15.1. Western Europe Tumor Profiling Market Overview
  • 15.2. Western Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Profiling Market

  • 16.1. UK Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Profiling Market

  • 17.1. Germany Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Profiling Market

  • 18.1. France Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Profiling Market

  • 19.1. Italy Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Profiling Market

  • 20.1. Spain Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Profiling Market

  • 21.1. Eastern Europe Tumor Profiling Market Overview
  • 21.2. Eastern Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Profiling Market

  • 22.1. Russia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Profiling Market

  • 23.1. North America Tumor Profiling Market Overview
  • 23.2. North America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Profiling Market

  • 24.1. USA Tumor Profiling Market Overview
  • 24.2. USA Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Profiling Market

  • 25.1. Canada Tumor Profiling Market Overview
  • 25.2. Canada Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Profiling Market

  • 26.1. South America Tumor Profiling Market Overview
  • 26.2. South America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Profiling Market

  • 27.1. Brazil Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Profiling Market

  • 28.1. Middle East Tumor Profiling Market Overview
  • 28.2. Middle East Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Profiling Market

  • 29.1. Africa Tumor Profiling Market Overview
  • 29.2. Africa Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Profiling Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Profiling Market Competitive Landscape
  • 30.2. Tumor Profiling Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Profiling Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Guardant Health Inc.
  • 31.5. GenScript Biotech Corporation
  • 31.6. NeoGenomics Inc.
  • 31.7. Caris Life Sciences Inc.
  • 31.8. Tempus Inc.
  • 31.9. Foundation Medicine Inc.
  • 31.10. NanoString Technologies Inc.
  • 31.11. Personalis Inc.
  • 31.12. Boreal Genomics Inc.
  • 31.13. Strand Life Sciences Pvt. Ltd.
  • 31.14. HTG Molecular Diagnostics Inc.
  • 31.15. Lucence Health Inc.

32. Global Tumor Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Profiling Market

34. Recent Developments In The Tumor Profiling Market

35. Tumor Profiling Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Profiling Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Profiling Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Profiling Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer